Gage Growth (GAEGF) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 6 48 sessions, December 31, 2021 to March 10, 2022
- Largest daily move
- -9.8% close of January 20, 2022
Company Description
Gage Growth (OTC: GAEGF) is classified in the drug manufacturers—specialty & generic industry within the Healthcare sector and carries a market capitalization of $193.8M.
GAEGF has declined 21.8% so far this year. The last closing price was $1.40.
This page collects what Stock Titan holds for GAEGF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Gage Growth (GAEGF) closed at $1.40 on March 10, 2022. So far this year, the price has lost 21.8%.
GAEGF Metrics & Rankings
Price returns through March 10, 2022. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Gage Growth has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition. View all GAEGF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
GAEGF Company Profile & Sector Positioning
Gage Growth (GAEGF) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector.
Investors comparing GAEGF often look at related companies in the same sector, including Mallinckrodt Plc (MNKPF), Lifecore Biomedical Inc. (LNDC), GNTW (GNTW), Recro Pharma Inc (REPH), and Harborside, Inc. (HBORF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate GAEGF's relative position within its industry.